Physician profile
Sarah Davis
NPI 1164051124
$17,665.78
in general payments reported to CMS, 2019-2025
72 companies · $4,453 in 2025
The $4,453 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,932 · 2022: $3,166 · 2023: $3,657 · 2024: $3,458 · 2025: $4,453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $780.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,787.28 |
| Education | $780.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,359.09 | 2021-2025 | Tecvayli, Darzalex, Talvey |
| Pfizer INC. | $1,185.24 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,019.80 | 2021-2025 | Tagrisso, Enhertu, Lynparza |
| Genzyme Corporation | $949.61 | 2021-2025 | |
| Celgene Corporation | $908.66 | 2021-2025 | Reblozyl, Pomalyst, Opdualag |
| Merck Sharp & Dohme LLC | $889.14 | 2021-2025 | Keytruda, Welireg, Reblozyl |
| Astellas Pharma US INC | $750.23 | 2021-2025 | Padcev, Xtandi, Xospata |
| Novartis Pharmaceuticals Corporation | $685.70 | 2021-2025 | |
| Incyte Corporation | $661.82 | 2021-2025 | Jakafi, Monjuvi, Pemazyre |
| E.R. Squibb & Sons, L.L.C. | $572.07 | 2021-2025 | Opdivo, Opdualag |
| Bayer Healthcare Pharmaceuticals INC. | $556.79 | 2021-2025 | |
| Glaxosmithkline, LLC. | $548.00 | 2021-2025 | Jemperli, Zejula, Ojjaara |
| Lilly USA, LLC | $502.48 | 2021-2025 | Jaypirca, Verzenio, Retevmo |
| Abbvie INC. | $487.32 | 2021-2025 | |
| Seagen INC. | $392.42 | 2021-2025 | Tukysa, Tivdak, Adcetris |
Show all 72 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karyopharm Therapeutics INC. | $331.35 | 2021-2025 | Xpovio |
| Amgen INC. | $327.66 | 2021-2023 | Kyprolis, Lumakras, Blincyto |
| Sobi, INC | $316.90 | 2022-2025 | |
| Daiichi Sankyo INC. | $298.73 | 2021-2025 | Enhertu, Injectafer, Datroway |
| Takeda Pharmaceuticals U.S.A., INC. | $286.92 | 2023-2025 | Alunbrig, Fruzaqla, Advate |
| Ipsen Biopharmaceuticals, INC | $286.51 | 2021-2025 | Onivyde, Somatuline Depot, Tazverik |
| Beone Medicines USA, INC. | $285.02 | 2025 | Brukinsa, Tevimbra |
| Pharmacyclics LLC, An Abbvie Company | $242.67 | 2021-2023 | Imbruvica, Epkinly |
| Boehringer Ingelheim Pharmaceuticals, INC. | $239.22 | 2021-2025 | |
| Jazz Pharmaceuticals INC. | $236.76 | 2021-2025 | |
| Dova Pharmaceuticals | $224.78 | 2021 | |
| Mirati Therapeutics, INC. | $218.22 | 2023-2024 | Krazati |
| Caris Mpi, INC. | $170.33 | 2025 | Mi Cancer Seek |
| Genentech USA, INC. | $155.40 | 2023-2025 | Tecentriq, Polivy, Itovebi |
| Exelixis INC. | $146.52 | 2022-2025 | Cabometyx |
| Regeneron Healthcare Solutions, INC. | $145.50 | 2021-2024 | Libtayo |
| Pharmaessentia USA Corporation | $140.77 | 2023-2025 | Besremi |
| Eisai INC. | $136.18 | 2021-2024 | |
| Array Biopharma INC | $126.99 | 2021-2025 | Braftovi, Lorbrena, Mektovi |
| Kite Pharma, INC. | $125.00 | 2024 | Yescarta |
| Foundation Medicine, INC. | $117.20 | 2021-2023 | |
| Emd Serono, INC. | $111.73 | 2022-2025 | Bavencio |
| Servier Pharmaceuticals LLC | $109.69 | 2022-2025 | |
| Coherus Oncology, INC. | $104.72 | 2021-2024 | |
| Pharmacosmos Therapeutics INC. | $103.01 | 2023-2025 | Monoferric |
| Legend Biotech USA INC. | $79.39 | 2024-2025 | Carvykti |
| Sun Pharmaceutical Industries INC. | $78.16 | 2023-2025 | Odomzo, Yonsa |
| Ge Healthcare | $75.47 | 2025 | |
| Puma Biotechnology, INC. | $70.36 | 2021-2022 | |
| Kyowa Kirin, INC. | $69.06 | 2021-2025 | Poteligeo |
| Tempus Ai, INC | $63.74 | 2025 | Xt Cdx |
| Fennec Pharmaceuticals, INC. | $61.52 | 2024-2025 | Pedmark, Fyarro |
| Amneal Pharmaceuticals LLC | $60.48 | 2023-2025 | Alymsys, Neulasta, Avastin |
| Taiho Oncology, INC. | $52.71 | 2023-2025 | |
| Recordati_rare_diseases_inc. | $41.73 | 2024 | Sylvant |
| Adc Therapeutics America, INC. | $40.77 | 2021-2025 | |
| Geron Corporation | $40.23 | 2025 | Rytelo |
| Dendreon Pharmaceuticals LLC | $37.39 | 2021-2025 | Provenge |
| Tolmar Pharmaceuticals, INC. | $36.69 | 2022 | |
| G1 Therapeutics, INC. | $36.60 | 2022-2023 | Cosela |
| Stemline Therapeutics INC. | $34.17 | 2024-2025 | Orserdu |
| Deciphera Pharmaceuticals INC. | $32.97 | 2023 | Qinlock |
| Acrotech Biopharma INC. | $30.51 | 2022-2023 | Beleodaq |
| Spectrum Pharmaceuticals INC. | $25.71 | 2025 | Rolvedon |
| Azurity Pharmaceuticals, INC. | $24.46 | 2025 | Danziten |
| Octapharma USA, INC. | $23.76 | 2023 | Panzyga |
| Progenics Pharmaceuticals, INC. | $21.48 | 2024 | |
| Novocure INC. | $20.63 | 2025 | Optune Lua (Novottf-200t) |
| Gilead Sciences, INC. | $19.74 | 2025 | Trodelvy |
| Beigene USA, INC. | $18.86 | 2023 | Brukinsa |
| Tersera Therapeutics LLC | $18.82 | 2021 | |
| Accord Healthcare, INC. | $18.21 | 2024 | |
| Heron Therapeutics, INC. | $17.16 | 2022 | |
| Morphosys, US INC. | $16.67 | 2021 | |
| Immunogen, INC. | $14.88 | 2023 | Elahere |
| Myriad Genetic Laboratories, INC. | $14.49 | 2021 | |
| Alexion Pharmaceuticals, INC. | $12.81 | 2023 | Ultomiris |
Drugs and devices associated with these payments
Tecvayli $763Darzalex $668Keytruda $640Reblozyl $606Xtandi $439Jemperli $362Sarclisa $328Talvey $293Zejula $268Tagrisso $251Opdivo $240Padcev $237Brukinsa $237Jakafi $236Jaypirca $224Pluvicto $222Krazati $218Tukysa $213Ibrance $206Xofigo $194Nubeqa $194Bosulif $193Enhertu $193Imbruvica $192Orgovyx $186Elrexfio $184Mi Cancer Seek $170Verzenio $167Kisqali $156Lynparza $155Welireg $155Adcetris $154Talzenna $146Lenvima $142Besremi $141Lutathera $130Erleada $125Yescarta $125Vonjo $122Comirnaty $114Doptelet $109Monoferric $103Onivyde $96.25Braftovi $92.99Lorbrena $92.99Promacta $92.38Opdualag $86.07Venclexta $85.83Jevtana $85.82Udenyca $85.65Xpovio $83.79Alunbrig $81.43Fruzaqla $79.45Kyprolis $78.10Lumakras $76.28Tecentriq $75.44Retevmo $75.08Lupron Depot $70.82Mektovi $69.63Pomalyst $67.85Tevimbra $67.06Piqray $66.37Xt Cdx $63.74Carvykti $63.72Monjuvi $63.37Injectafer $63.16Stivarga $62.78Vitrakvi $62.78Paxlovid $62.72Tibsovo $62.46Libtayo $60.90Somatuline Depot $57.18Elitek $56.37Balversa $55.27Inqovi $52.71Lonsurf $52.71Keytruda Qlex $50.46Cabometyx $46.53Polivy $43.84Pemazyre $43.74Pedmark $43.24Cequa $43.13Epkinly $42.79Elahere $42.27Sylvant $41.73Rytelo $40.23Odomzo $35.03Yonsa $35.03Tivdak $34.92Akeega $34.85Orserdu $34.17Ojjaara $33.61Qinlock $32.97Advate $32.83Zepzelca $31.66Enjaymo $31.54Poteligeo $30.55Besponsa $29.93Datroway $27.47Inlyta $26.75
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.